CD34 and glioblastoma: Thus, angiogenesis is considered as a pathologic hallmark of GB, leading to VEGF activation, an angiogenic growth factor that promotes glioblastoma proliferation and CD34 activation, a transmembrane glycoprotein involved in the process of newly-forming tumour vessels [25,42].